@article{Avadhesh Sharma_Sriram Chandra Mishra_Vandana Gupta_2023, place={India.}, title={Randomised Controlled Clinical Study of Shatyadi Kwatha in Amavata (Rheumatoid Arthritis)}, volume={10}, url={https://ayushdhara.in/index.php/ayushdhara/article/view/1167}, DOI={10.47070/ayushdhara.v10iSuppl1.1167}, abstractNote={<p>The disease <em>Amavata </em>simulate with Rheumatoid Arthritis (RA) in modern parlanceis a symmetric, inflammatory, peripheral polyarthritis of unknown etiology with systemic involvement caused by the impairment of <em>Agni</em> (digestive fire), formation of <em>Ama</em> (bio-toxin) and vitiation of <em>Vata Dosha</em>. The disease <em>Amavata</em> (rheumatoid arthritis) still is a challenge to the physician due to its chronicity, incurability, complications, morbidity and crippling nature. A clinical study was conducted for 45 days at V.Y.D.S Ayurved Mahavidyalaya, Khurja, on 30 patients divided them into two groups of 15 each, to compare the efficacy of <em>Shatyadi kwatha </em>with the well-established control drug <strong><em>Maharasnadi Kwatha</em></strong> in the management of <em>Amavata </em>(rheumatoid arthritis). The demographic data of this study reveals that <em>Amavata</em> (rheumatoid arthritis) can begin at any age, but incidence increases with age. It clearly shows the predominance of the disease in females, in housewives, in addiction of tea/coffee and in <em>Samashana</em> group (consuming suitable and unsuitable foods mixed together). The clinical data of this study reveals that, both the drugs were found capable to enforce relief, but based on % of improvement and clinical assessment of result, it can be concluded that control drug (<strong><em>Maharasnadi Kwatha</em></strong>) was more effective than trial drug (<em>Shatyadi kwatha</em>) in most of the sign and symptom of the disease at extremely significant level.</p>}, number={Suppl1}, journal={AYUSHDHARA}, author={Avadhesh Sharma and Sriram Chandra Mishra and Vandana Gupta}, year={2023}, month={Mar.}, pages={8-18} }